EXN 40% v36,9M c1.38 f33,1M H1.75 morning gapNfade

New Post Public Reply Private Reply Replies (0) Message Board
znewcar1
231
EXN 40% v36,9M c1.38 f33,1M H1.75 morning gapNfade

Excellon Resources Inc. (EXNRF) Stock Research Links

EXNRF Board Company Profile Buy Rating Time & Sales News Filings Financials
The majority of my post are the top 20% gainer! To decode them its (ticker ID, % Changed, Volume, Close price and Float) I typically put V,C&F as a prefix to that number and use K, M and B as a suffix (Kilo, Million & Billion) for volume and float. I may also use S for Support and R for Resistance.

I (Znewcar1) do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor.
All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies.
I will not and cannot be held liable for any actions you take as a result of anything you read here.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Firehawk Defense Secures $150M, Valuation Hits $1.4B

Updated Category News Views 0

Firehawk Defense Lands Major Funding Think about it—Firehawk Defense, a gutsy Dallas-based new-kid-on-the-block, just snagged a whopping $150 million in fresh funding. The news? Their valuation's now sitting pretty at $1.4 billion. Not peanuts, by any means. For a company in the artillery game, that's a blast of an announcement. They're predicting they'll become the big...

Continue Reading
Infrastructure Capital's ETFs: Dividend Windfall

Updated Category News Views 63

Payout Boost for Income-Hungry Investors You know, it ain't every day you hear about dividend increases across the board. But Infrastructure Capital Advisors, that investment management powerhouse, is dishing out more dough to its investors through a dividend uptick. They're bumping up the payouts on not just one, but four of their ETFs: Bond Income ETF (BNDS), Equity...

Continue Reading
RKD Groups' New Initiative: Monthly Giving Accelerator

Updated Category News Views 0

Something’s cooking in the nonprofit realm, and it ain’t business as usual. RKD Group is stirring the pot big time with their latest endeavor: the Monthly Giving Accelerator. They’ve roped in Dana Snyder, who’s got a track record working with big guns like the Canadian Red Cross and Movember. Let’s just say she's got a Ph.D. in monthly donations. What’s the...

Continue Reading
Shira Goodman Joins APEI Board: New Direction?

Updated Category News Views 72

A New Chapter for American Public Education Alright, sit tight because this one’s got layers. American Public Education, Inc. (Nasdaq: APEI) just shook up its board by bringing in Shira Goodman, the former CEO of Staples. This move isn't just swapping one name for another; it’s about bolstering leadership at a time when strategic decisions are pivotal. Who is Shira...

Continue Reading
Billd's Flex Line: Game-Changer for Subcontractor Credit

Updated Category News Views 122

Billd's Bold Move Across America Forget piecemeal rollouts; Billd's taking their latest brainchild, Flex Line, right into the heart of America's subcontractor landscape. This isn't some flash-in-the-pan financial offering, either—it's a heavy-hitter poised to shake up the way subcontractors wrangle their working capital. We're talking about a line of credit that's as...

Continue Reading
MetaOptics Bolsters Strategies with Buy-Back Mandate

Updated Category News Views 0

Strategic Moves by MetaOptics If you thought the optics game was settled ages ago, think again. Today, MetaOptics Ltd (Catalist: 9MT), from sunny Singapore, is stirring up the pot with their latest game plan—a freshly minted Share Buy-Back Mandate. Shareholders at their general meeting were all thumbs up, and that's no surprise given what's on the table. Aim for...

Continue Reading
Microplastics Found in Human Blood: Alarming Evidence

Updated Category News Views 106

An Unsettling Discovery in Our Veins Microplastics in the blood? Yep, you read that right, and it’s not some sci-fi horror story—it’s today’s harsh reality. A riveting report from the likes of the Plastic Pollution Coalition and the Canadian Association of Physicians for the Environment has thrown a bucket of cold water on us. They uncovered microplastics in 96%...

Continue Reading
Farizon SV 2027 Debuts in France Amid Market Shifts

Updated Category News Views 72

A New Entry in the European Delivery Market The game's changing in European delivery, folks, and you better believe Geely Farizon's got a stake in it. Rolling out their all-electric Farizon SV Model Year 2027 at the world-renowned Marché International de Rungis, these folks are nothing if not ambitious. Nestled in the heart of the produce distribution world, Rungis...

Continue Reading
D-Wave Faces Class Action: Investors Seek Justice

Updated Category News Views 60

When you hear a heavyweight like D-Wave Quantum Inc. finding itself tangled in a securities fraud lawsuit, you know there’s something big brewing. D-Wave Quantum Inc. NASDAQ: QBTS is under the spotlight and the clock is ticking. If you've dipped your toes into their stock between February 26, 2026, and August 25, 2026, chances are, this might be your ticket to seek some...

Continue Reading
Astemo Flexes Aftermarket Muscles at 2026 AAPEX & SEMA

Updated Category News Views 90

Ah, nothing gets car enthusiasts more revved up than a good old-fashioned auto show unveiling. Astemo Americas is strutting its stuff at the 2026 AAPEX and SEMA shows, and they're not just shooting the breeze—this company has got some serious aftermarket muscle to flex. Pumping Up the Aftermarket Game Astemo's not sitting on its hands when it comes to expanding its...

Continue Reading

Top 5 Most Recently Viewed Articles

Key Stock Movements: AMD and J&J Highlight Market Changes

Updated Category News Views 148

Overview of Wednesday's Market Movements On a lively trading Wednesday, the stock market witnessed remarkable movements, predominantly influenced by mega-cap and large-cap stocks. Investors were actively processing various news and market dynamics that had significant impacts on intra-day stock performance. This article breaks down the noteworthy stock movers of the...

Continue Reading
RBG Holdings Terminates Consultancy with Ian Rosenblatt

Updated Category News Views 120

RBG Holdings Ends Ian Rosenblatt's Consultancy Agreement RBG Holdings plc (AIM: RBGP), a well-known provider of legal services, is taking significant steps to uphold its integrity by terminating the consultancy agreement with Ian Rosenblatt. This decision comes after the company identified multiple breaches of the agreement, along with serious violations of restrictive...

Continue Reading
Rehabtronics Teams Up with PressureSmart for Injury Prevention

Updated Category News Views 60

Rehabtronics Partners with PressureSmart Consortium Rehabtronics, a leader in neurostimulation technology, has launched an important partnership with the PressureSmart Consortium. This collaboration includes six respected partners, such as Medtronic and Thrive Health, with the goal of innovating pressure injury prevention technology within the healthcare industry. The...

Continue Reading
FanDuel Expands Engagement with Innovative Bet Tracking Feature

Updated Category News Views 227

Transformative Bet Tracking Experience by FanDuel Combining scale and technology, FanDuel is redefining sports fan engagement. FanDuel, recognized as a leading online gaming company, has partnered with Main Street Sports Group to launch an exciting new feature: Bet Tracking. Fans can now enjoy a more interactive experience while watching live NBA and NHL games on the...

Continue Reading
Greenwich LifeSciences Advances Manufacturing of GP2 for Breast Cancer

Updated Category News Views 324

Greenwich LifeSciences Updates on GP2 Commercial Manufacturing Greenwich LifeSciences, Inc. (Nasdaq: GLSI), a clinical-stage biopharmaceutical entity dedicated to developing innovative therapies, has recently shared important progress regarding the commercial manufacturing of GP2, aimed at reducing the risk of breast cancer recurrence. This initiative is part of their...

Continue Reading